Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gain Therapeutics (GANX) Interest & Investment Income (2024 - 2025)

Gain Therapeutics (GANX) has 2 years of Interest & Investment Income data on record, last reported at $78074.0 in Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 25.93% year-over-year to $78074.0; the TTM value through Sep 2025 reached $212912.0, changed N/A, while the annual FY2024 figure was $357096.0, 27.75% down from the prior year.
  • Interest & Investment Income reached $78074.0 in Q3 2025 per GANX's latest filing, up from $42568.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $115303.0 in Q1 2024 and bottomed at $40413.0 in Q1 2025.